• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

竞争风险导致的死亡是否会影响中国和高社会人口指数国家的 COPD 模式?:对 2017 年全球疾病负担研究汇总统计数据的横断面分析。

Do deaths from competing risks influence COPD patterns in China and high socio-demographic index countries?: a cross-sectional analysis of summary statistics from the Global Burden of Disease Study 2017.

机构信息

School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China

出版信息

BMJ Open. 2022 Mar 23;12(3):e050080. doi: 10.1136/bmjopen-2021-050080.

DOI:10.1136/bmjopen-2021-050080
PMID:35321891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8943480/
Abstract

OBJECTIVE

To explore possible reasons for the difference in chronic obstructive pulmonary disease (COPD) incidence/mortality rates between China and high socio-demographic index (SDI) countries.

DESIGN

A cross-sectional analysis of summary statistics from the Global Burden of Disease Study 2017.

PARTICIPANTS

Data were publicly available and de-identified, and individuals were not involved.

MEASUREMENT AND METHODS

We extracted the age-standardised and age-specific incidence/mortality rates, and risk factors attributed to COPD in China and high SDI countries from the Global Burden of Disease Study 2017. We first described differences in COPD patterns (ie, incidence and mortality rates) in China and high SDI countries briefly, and then explored possible reasons for driving such differences by comparing rankings for six well-established COPD risk factors and estimating change points in age-specific incidence and mortality rates for COPD and several commonly encountered competing risks using segmented regression models.

RESULTS

Differences in age-standardised incidence and mortality rates for COPD between China and high SDI countries converged during 1990-2017 but still differed, particularly for mortality rates. Smoking was the leading attributable risk factor followed by ambient air pollution, with higher rankings for occupational risks in China than in high SDI countries. The change point was 80 years for age-specific COPD mortality rate in both China and high SDI countries. However, the change point for COPD incidence was 5-year later in China (65 years) than in high SDI countries (~60 years). The change points for mortality rates due to competing risks (eg, ischaemic heart disease) also varied between settings.

CONCLUSION

Differences in risk factors largely shaped the differences in COPD patterns between China and high SDI countries. Varying patterns of mortality due to competing risks might also contribute to the discrepancy in COPD mortality rates, by affecting the survival of the underlying population.

摘要

目的

探究中国与高社会人口指数(SDI)国家间慢性阻塞性肺疾病(COPD)发病率/死亡率差异的可能原因。

设计

对 2017 年全球疾病负担研究的汇总统计数据进行的横断面分析。

参与者

数据公开且去识别,不涉及个体。

测量和方法

我们从 2017 年全球疾病负担研究中提取了中国和高 SDI 国家的 COPD 的年龄标准化和年龄特异性发病率/死亡率以及归因于 COPD 的危险因素。我们首先简要描述了中国和高 SDI 国家 COPD 模式(即发病率和死亡率)的差异,然后通过比较六个公认的 COPD 危险因素的排名,并使用分段回归模型估计 COPD 和几种常见的竞争风险的特定年龄发病率和死亡率的转折点,探讨导致这种差异的可能原因。

结果

1990-2017 年期间,中国和高 SDI 国家的 COPD 的年龄标准化发病率和死亡率差异趋同,但仍存在差异,尤其是死亡率。吸烟是主要的归因危险因素,其次是环境空气污染,中国的职业风险排名高于高 SDI 国家。中国和高 SDI 国家的 COPD 死亡率的特定年龄变化点均约为 80 岁。然而,中国 COPD 发病率的变化点比高 SDI 国家晚 5 年(约 65 岁)。竞争风险(如缺血性心脏病)导致的死亡率的变化点也因环境而异。

结论

危险因素的差异在很大程度上塑造了中国与高 SDI 国家 COPD 模式的差异。由于竞争风险导致的死亡率模式的不同,也可能通过影响基础人群的生存,导致 COPD 死亡率的差异。

相似文献

1
Do deaths from competing risks influence COPD patterns in China and high socio-demographic index countries?: a cross-sectional analysis of summary statistics from the Global Burden of Disease Study 2017.竞争风险导致的死亡是否会影响中国和高社会人口指数国家的 COPD 模式?:对 2017 年全球疾病负担研究汇总统计数据的横断面分析。
BMJ Open. 2022 Mar 23;12(3):e050080. doi: 10.1136/bmjopen-2021-050080.
2
Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.全球疾病负担研究 2019 数据分析显示,1990 年至 2019 年,按社会人口指数、年龄和性别划分的导致 COPD 的全球负担的分布和趋势:系统分析
Respir Res. 2022 Apr 11;23(1):90. doi: 10.1186/s12931-022-02011-y.
3
Global burden of chronic obstructive pulmonary disease attributable to ambient particulate matter pollution and household air pollution from solid fuels from 1990 to 2019.2019 年,源于环境细颗粒物污染和固体燃料室内空气污染的全球慢性阻塞性肺疾病负担。
Environ Sci Pollut Res Int. 2022 May;29(22):32788-32799. doi: 10.1007/s11356-021-17732-8. Epub 2022 Jan 12.
4
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年食管痛的全球、区域和国家负担及其可归因风险因素:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1.
5
Global burden of chronic obstructive pulmonary disease attributable to ambient ozone in 204 countries and territories during 1990-2019.1990 - 2019年期间204个国家和地区因环境臭氧导致的慢性阻塞性肺疾病全球负担
Environ Sci Pollut Res Int. 2022 Feb;29(6):9293-9305. doi: 10.1007/s11356-021-16233-y. Epub 2021 Sep 9.
6
Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.1990 - 2019年慢性呼吸道疾病及其风险因素的全球负担:全球疾病负担研究2019年的最新情况
EClinicalMedicine. 2023 May;59:101936. doi: 10.1016/j.eclinm.2023.101936.
7
Burden of chronic obstructive pulmonary disease attributable to non-optimal temperature from 1990 to 2019: a systematic analysis from the Global Burden of Disease Study 2019.2019 年全球疾病负担研究:1990 年至 2019 年非最适温度导致的慢性阻塞性肺疾病负担:系统分析。
Environ Sci Pollut Res Int. 2023 Jun;30(26):68836-68847. doi: 10.1007/s11356-023-27325-2. Epub 2023 May 2.
8
Global burden of COPD attributable to ambient PM2.5 in 204 countries and territories, 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990 年至 2019 年与环境 PM2.5 相关的 COPD 全球负担:2019 年全球疾病负担研究的系统分析。
Sci Total Environ. 2021 Nov 20;796:148819. doi: 10.1016/j.scitotenv.2021.148819. Epub 2021 Jul 9.
9
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019.中国及各省 COPD 负担:来自 2019 年全球疾病负担研究的发现。
Front Public Health. 2022 Jun 3;10:859499. doi: 10.3389/fpubh.2022.859499. eCollection 2022.
10
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.1990-2015 年 195 个国家和地区的吸烟流行率和可归因疾病负担:来自 2015 年全球疾病负担研究的系统分析。
Lancet. 2017 May 13;389(10082):1885-1906. doi: 10.1016/S0140-6736(17)30819-X. Epub 2017 Apr 5.

引用本文的文献

1
Breastfeeding and ApoB in late adolescence: a Hong Kong birth cohort study.青少年晚期母乳喂养与载脂蛋白 B:一项香港出生队列研究。
Eur J Pediatr. 2023 Aug;182(8):3733-3741. doi: 10.1007/s00431-023-05033-w. Epub 2023 Jun 8.

本文引用的文献

1
Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990-2017 年慢性呼吸道疾病的流行情况和可归因健康负担:2017 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.
2
Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017.1990 年至 2017 年慢性呼吸道疾病的死亡率和伤残调整生命年的趋势和风险因素:2017 年全球疾病负担研究的系统分析。
BMJ. 2020 Feb 19;368:m234. doi: 10.1136/bmj.m234.
3
The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.
慢性阻塞性肺疾病(COPD)在美国、欧洲和亚洲的经济负担:文献系统综述的结果。
Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):661-672. doi: 10.1080/14737167.2020.1678385. Epub 2019 Oct 18.
4
The burden of injury in China, 1990-2017: findings from the Global Burden of Disease Study 2017.中国 1990-2017 年的伤害负担:2017 年全球疾病负担研究的结果。
Lancet Public Health. 2019 Sep;4(9):e449-e461. doi: 10.1016/S2468-2667(19)30125-2.
5
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.死亡率、发病率和风险因素在中国及其省份,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24.
6
Under- and over-diagnosis of COPD: a global perspective.慢性阻塞性肺疾病的漏诊与误诊:全球视角
Breathe (Sheff). 2019 Mar;15(1):24-35. doi: 10.1183/20734735.0346-2018.
7
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
8
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
9
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
10
COPD in China: From Crisis to Hope….中国的慢性阻塞性肺疾病:从危机到希望……
Chest. 2018 Sep;154(3):474-475. doi: 10.1016/j.chest.2018.07.012.